HF
SRNE

HRT Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

HRT Financial’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17,000
Closed -$34K – 3780
2022
Q2 		$34K Buy
+17,000
New +$29.4K ﹤0.01% 2552
2020
Q4 		– Sell
-31,100
Closed -$346K – 2675
2020
Q3 		$346K Buy
+31,100
New +$285K 0.01% 1061

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HRT Financial's SRNE Position: Q2 2021 in Review

HRT Financial sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2021, closing a stake of 56,059 shares — an estimated $463K sold.

HRT Financial first reported a position in SRNE in Q3 2018 and held it in 6 quarters. The position peaked at $463K in Q1 2021. 212 funds tracked by Wall St. Rank hold SRNE as of Q2 2021.

  • HRT Financial reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • HRT Financial sold 56,059 Sorrento Therapeutics, Inc. shares in Q2 2021, an estimated $463K.
  • HRT Financial first reported a position in Sorrento Therapeutics, Inc. in Q3 2018 and held it in 6 quarters.
  • HRT Financial's Sorrento Therapeutics, Inc. position peaked at $463K in Q1 2021.
  • 212 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2021.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.